Alopecia Areata | An Evidence-Based Approach to Treatment
Alopecia areata is a form of non-scarring hair loss that affects both children and adults, causing significant quality of life impairment. Varying from localized to widespread hair loss, including alopecia totalis and universalis variants, alopecia areata can be self-resolving or chronic in its course. For years and in some cases centuries, treatment was limited to caustic substances that irritate …
Alopecia areata is a form of non-scarring hair loss that affects both children and adults, causing significant quality of life impairment. Varying from localized to widespread hair loss, including alopecia totalis and universalis variants, alopecia areata can be self-resolving or chronic in its course. For years and in some cases centuries, treatment was limited to caustic substances that irritate … Continue reading "Alopecia Areata | An Evidence-Based Approach to Treatment"
Cutaneous T cell lymphoma (CTCL) is the most common primary cutaneous lymphoma, and in some patients, it could be persistent for decades. Therapy for CTCL depends on disease stage and response to prior treatments. In this month’s installment of Therapeutic Cheat Sheets, we will discuss use of bexarotene for the treatment of CTCL.
BEXAROTENE THERAPEUTIC CHEAT SHEET
Compiled by: Adrianna Gonzale … 
The gut-immune-skin axis describes how the gut microbiome communicates with the skin via complex interactions with the immune system to regulate local and systemic inflammation. Before attempting to delineate that relationship, we must first grasp a firm understanding of the gut ecosystem. The gut ecosystem is made up of the epithelial interface, which is characterized by
the epithelial … 
The May issue of the Journal of Drugs in Dermatology features dermatology articles on topics ranging from treatment updates on Port-Wine stain to the protective effect that liposomal bovine colostrum exerts on skin aging using telomere length as an aging biomarker. Straight from the JDD Editor’s desk, we share this month’s issue highlights:
Authors analyze extrusion forces of various produ … 
Case Scenario
A 26-year-old patient presents to the dermatology clinic with severe nodulocystic scarring acne. The patient identifies as a transgender male and notes that he has been receiving hormone replacement therapy for the past 4 years with weekly intramuscular testosterone injections. He has not had any gender-affirming surgeries and reports being currently amenorrhoeic. He is curren … 